Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 2/20 | 0.30 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2235175 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL29535036 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL30143329 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL8462241 | 0.89 | DRD2 (0.31) | KIF11PARP1 | |
| Hydrochloric Acid SCHEMBL31571595 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL31571613 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL16393603 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL30143324 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL3816048 | 0.87 | SYK (0.30) | — | |
| Hydrochloric Acid SCHEMBL30133762 | 0.87 | BRD4 (0.32) | BRD4CREBBPPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118852510-A | Catalytic composition and application thereof in olefin polymerization hydrogen level regulation | 中化学科学技术研究有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-115785313-B | Polypropylene and preparation method thereof | LG化学株式会社 | 2024-02-23 | — | — | CN | disclosed |
| CN-115785313-A | Polypropylene and preparation method thereof | LG化学株式会社 | 2023-03-14 | — | — | CN | disclosed |
| CN-110099934-B | Polypropylene and preparation method thereof | LG化学株式会社 | 2023-01-31 | — | — | CN | disclosed |
| CN-112154163-B | Transition metal compound and method for preparing polypropylene using the same | LG化学株式会社 | 2022-12-27 | — | — | CN | disclosed |
| US-20220363703-A1 | CATALYSTS | BOREALIS AG (AT) | 2022-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220363703-A1 | CATALYSTS | SOD1, MT-CO2, MT-CO1 | BRD4 3030/4885CREBBP 2606/4885KIF11 614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.